DeepMind spin-out focused on AI-driven drug discovery, led by Demis Hassabis.
“I think of the prominent AI leaders, I think Demis does a pretty good job of actually translating the technology into more quantifiable and tangible ways for like your every person.”
Source→“Momentum shows up in named pharma partnerships (Novartis, Lilly, Johnson & Johnson), a mix of partnered and wholly owned programs, and the company's push to move internal assets toward the clinic.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.